Genetic Alteration Profiling of Chinese Lung Adenocarcinoma and Its Effect on Targeted Therapy Efficacy.

Liu, Jie; Xu, Wang-Yang; Ye, Maosong; Liu, Zilong; Li, Chun

Liu, Jie; Xu, Wang-Yang; Ye, Maosong; Liu, Zilong; Li, Chun.

Afiliação

Liu J; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Xu WY; Department of Medicine, Singlera Genomics (Shanghai) Ltd., Shanghai, China.
Ye M; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Liu Z; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Li C; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.

Front Oncol ; 11: 726547, 2021.

Article em En | MEDLINE | ID: mdl-34970478

Palavras-chave

genetic alteration; lung adenocarcinoma; next-generation sequencing (NGS); targeted therapy; tumor mutation burden (TMB)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article